We help communities to created a custom knowledge base(still being refined)
Click here to view original web page at Anxiety and Depression in Parkinson’s Disease
Image by Juliya Shangarey via Shutterstock Receivinga diagnosis of Parkinson’sdisease (PD) can be alife-alteringevent. When a person has symptoms of anxietyand depression, we may thinkthat’sa”normal” response tosuch an event.However, thesesymptoms maybe muchmore profoundthan aresponse. There is evidence that mood disorders such as anxiety and depression are not only the […]
BRISBANE, Calif., Nov. 11, 2021 /PRNewswire/ — Second Genome, a biotechnology company that leverages its proprietary platform sg-4sight to discover and develop precision therapies and biomarkers, presented two posters at the Society for Neuroscience’s (SfN) 50 th Annual Meeting (“Neuroscience 2021”) held virtually November 8-11. Abstract #: P045.05* Title: […]
After several decades of pre-clinical development, cell- and gene-based therapies for Parkinson’s disease (PD) are now actively being explored. In this special supplement to the Journal of Parkinson’s Disease on “Repairing the Parkinsonian Brain,” experts highlight some of the current strategies being pursued to restore lost function and replace […]
The USC Mark and Mary Stevens Neuroimaging and Informatics Institute (USC Stevens INI), part of the Keck School of Medicine of USC, has launched a $3 million study that will unite researchers and data from 20 countries to answer some of the most pressing questions about Parkinson’s disease (PD). […]
Click here to view original web page at Mini-brains in lab mimic Parkinson’s disease
By manipulating the DNA of the starting stem cells to match genetic risk factors found in patients with Parkinson’s disease, the study scientists were able to grow organoids with neurons that showed both Lewy bodies and the progressive loss of dopamine-producing neurons. Mini-brains in lab mimic Parkinson’s disease(Photo:Associate Professor […]
Upwards of 10 million people globally and nearly one million in the United States live with Parkinson’s disease , which has no approved treatments . The only option for patients is drugs that can keep the degenerative condition in check, rather than tackle its root causes. A group of […]
The organoids enable scientists to study how the human brain develops and communicates. Image courtesy: IANS Singapore: A team of researchers here has for the first time grown tiny brains-in-a-dish that mimic the major pathological features of Parkinson’s disease — a common age-related neurodegenerative disorder. The research, led by […]
Credit: Pixabay/CC0 Public Domain A new study led by Dr. Beth Parkin, senior lecturer in psychology from the Cognitive Neuroscience Group at the University of Westminster, has discovered that a substantial proportion of people with Parkinson’s disease have precise deficits when learning from instructions, and these problems are associated […]
Click here to view original web page at Drug Shows Promise in Easing Dementia-Linked Psychosis
FRIDAY, July 23, 2021 (HealthDay News) — A drug that eases hallucinations in people with Parkinson’s disease may be able to do the same for those with dementia, a new clinical trial finds. The medication, called Nuplazid (pimavanserin), is already approved in the United States for treating hallucinations and […]
Click here to view original web page at www.wdtv.com
MORGANTOWN, W.Va (WDTV) – WVU Medicine’s, “Rockefeller Neuroscience Institute” preformed a new procedure to help people with Parkinson’s. Vice President of the Institute, Dr. Ali Rezai said the new deep brain stimulation or DBS technology allowed them to perform this groundbreaking procedure. The new DBS tech was essentially a […]
